Navigation Links
Chewable Aspirin More Readily Absorbed
Date:5/15/2009

Study suggests higher levels found in bloodstream could improve heart attack treatments

FRIDAY, May 15 (HealthDay News) -- Chewable aspirin is more readily absorbed into the bloodstream, making it the best aspirin choice for people suffering a cardiac incident, University of California, San Diego researchers report.

Volunteers who consumed chewable aspirin had higher levels of aspirin in their blood shortly afterward when compared with people who either swallowed regular aspirin whole or chewed then swallowed regular aspirin, according to the study, scheduled to be presented Friday at the Society for Academic Emergency Medicine's annual meeting in New Orleans.

Doctors sometimes prescribe aspirin to people who have had a cardiac incident or are at high risk for one.

Study abstracts also appear in the suplement to the April issue of Academic Emergency Medicine.

More information

The American Heart Association has more about using aspirin for heart conditions.



-- Kevin McKeever



SOURCE: Society for Academic Emergency Medicine, news release, May 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
3. Perrigo Company Announces Final FDA Approval for OTC Famotidine Complete Chewable Tablets
4. Cavities in Children Reduced Over 60 Percent by New Experimental Chewable Mints
5. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
8. New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
9. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
10. Aspirin Resistance Boosts Heart Risks in Cardiac Patients
11. Regular, long-term aspirin use reduces risk of colorectal cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chewable Aspirin More Readily Absorbed
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... , ... April 24, 2017 , ... Michael Vick announced ... transforming the quarterback position. The former overall number one pick in the 2001 NFL ... career. He holds the record for the most career rushing yards by a quarterback ...
(Date:4/24/2017)... ... April 24, 2017 , ... NEPC Director Kevin Welner ... Education Research Award. The award honors scholars exemplary in their capacity to communicate ... who has demonstrated the capacity to deepen the public’s understanding and appreciation of ...
(Date:4/24/2017)... ... 2017 , ... Sean Fay is the undisputed king of the infomercial. With ... the George Foreman Grill (which sold more than 100 million units worldwide), he has ... , Now, due to changes in the broadcast media landscape, the once ever-present infomercial ...
(Date:4/24/2017)... Virginia (PRWEB) , ... April 24, 2017 , ... ... announced that they are seeking public support to bring their novel lifesaving device ... appearance, wearable device packed with medical-grade sensors, specially designed to read a child’s ...
Breaking Medicine News(10 mins):
(Date:4/18/2017)...  Astute Medical, Inc., developer of biomarkers for better ... at the 2017 National Kidney Foundation (NKF) Spring ... April 22. Physicians will present data on two biomarkers, ... for acute kidney injury (AKI) during the management of ... Elevated levels of TIMP-2 and IGFBP-7 have been ...
(Date:4/18/2017)... , April 18, 2017  Socionext Inc. ... collaboration started in 2016, in which Socionext extracts ... SOINN". The companies achieved initial results in reading ... by Artificial Brain SOINN. The results will be ... Sight, April 19-21, at booths 4505 & 4507. ...
(Date:4/18/2017)... Mass. , April 18, 2017  Spero Therapeutics, ... for the treatment of bacterial infections, will present preclinical ... the treatment of multidrug resistant (MDR) Gram-negative infections at ... Diseases (ECCMID) April 22-25, 2017 in Vienna, ... ...
Breaking Medicine Technology: